Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue 7
Submit an article Journal homepage
919
Views
50
CrossRef citations to date
0
Altmetric
Review

Arming oncolytic viruses to leverage antitumor immunity

Tanja D de GruijlVU University Medical Center - Cancer Center Amsterdam, Department of Medical Oncology, Room VUmc-CCA 2.44, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands+31 20 4444063; [email protected]
,
Axel B JanssenVU University Medical Center - Cancer Center Amsterdam, Department of Medical Oncology, Room VUmc-CCA 2.44, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands+31 20 4444063; [email protected]
&
Victor W van BeusechemVU University Medical Center - Cancer Center Amsterdam, Department of Medical Oncology, Room VUmc-CCA 2.44, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands+31 20 4444063; [email protected]
Pages 959-971 | Published online: 10 May 2015

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Matthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, Shane Foo, Eva Crespo-Rodriguez, Galabina Bozhanova, Emmanuel Christian Patin, Martin McLaughlin, David Mansfield, Gabriella Baker, Lorna Grove, Malin Pedersen, Joan Kyula, Victoria Roulstone, Anna Wilkins, Fiona McDonald, Kevin Harrington & Alan Melcher. (2020) Combination therapy with oncolytic viruses and immune checkpoint inhibitors. Expert Opinion on Biological Therapy 20:6, pages 635-652.
Read now
Nicolas AS Sokolowski, Helen Rizos & Russell J Diefenbach. (2015) Oncolytic virotherapy using herpes simplex virus: how far have we come?. Oncolytic Virotherapy 4, pages 207-219.
Read now

Articles from other publishers (48)

Hadi Esmaeili Gouvarchin Ghaleh, Gazal Vakilzadeh, Ali Zahiri & Mahdieh Farzanehpour. (2023) Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery. Cell Communication and Signaling 21:1.
Crossref
Palaniyandi Muthukutty & So Young Yoo. (2023) Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective. Viruses 15:8, pages 1645.
Crossref
Xianwang Wang, Yihua Shen, Xingxia Wan, Xiaoqing Hu, Wen-Qi Cai, Zijun Wu, Qiang Xin, Xiaoqing Liu, Jingang Gui, Hong-Yi Xin & Hong-Wu Xin. (2023) Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy. Journal of Translational Medicine 21:1.
Crossref
Areej Shahbaz, Tehreem Mahmood, Muhammad Uzair Javed & Bilal Haider Abbasi. (2023) Current advances in microbial-based cancer therapies. Medical Oncology 40:7.
Crossref
Mobarakeh Ajam-Hosseini, Fatemeh Akhoondi & Mohammad Doroudian. (2023) Nano based-oncolytic viruses for cancer therapy. Critical Reviews in Oncology/Hematology 185, pages 103980.
Crossref
Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Malik E. Juweid, Kamal Al-Rabi, Mohammad Ma’koseh, Hikmat Abdel-Razeq & Asem Mansour. (2023) FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects. Cancers 15:4, pages 1063.
Crossref
Mohsin Bilal, Mohammed Nimir, David Snead, Graham S. Taylor & Nasir Rajpoot. (2022) Role of AI and digital pathology for colorectal immuno-oncology. British Journal of Cancer 128:1, pages 3-11.
Crossref
Ruhul Amin, Bapi R. Sarkar, Prosanta Pal, Amitava Roy & Talha B. Emran. (2023) Oncolytic viruses are a recent breakthrough in oncoimmune treatment: recent insights – correspondence. Annals of Medicine & Surgery 85:4, pages 1300-1301.
Crossref
M. Vindhya, M. N. Ramesh Bharadwaj, Kanthesh M. Basalingappa, T. S. Gopenath & Ashok Gnanasekaran. 2023. Targeted Cancer Therapy in Biomedical Engineering. Targeted Cancer Therapy in Biomedical Engineering 179 217 .
Christie Vermeulen, Tereza Brachtlova, Nikki Tol, Ida H. van der Meulen-Muileman, Jasmina Hodzic, Henri J. van de Vrugt & Victor W. van Beusechem. (2022) Evaluation of a Novel Oncolytic Adenovirus Silencing SYVN1. International Journal of Molecular Sciences 23:23, pages 15430.
Crossref
Alexander Malogolovkin, Alexander D. Egorov, Alexander Karabelsky, Roman A. Ivanov & Vladislav V. Verkhusha. (2022) Optogenetic technologies in translational cancer research. Biotechnology Advances 60, pages 108005.
Crossref
Adam Khorasanchi, Richard Wu, Kari Kendra & Claire Verschraegen. (2022) Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma. Cancers 14:21, pages 5325.
Crossref
E. N. Loginova, E. A. Lyalyukova, E. V. Nadey & E. V. Semenova. (2022) Basics of immunooncology and immunotherapy in oncology. Experimental and Clinical Gastroenterology:9, pages 129-139.
Crossref
David A. HormuthIIII, Maguy Farhat, Chase Christenson, Brandon Curl, C. Chad Quarles, Caroline Chung & Thomas E. Yankeelov. (2022) Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy. Advanced Drug Delivery Reviews 187, pages 114367.
Crossref
Andrea Alberti & Paolo Bossi. (2022) Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives. Frontiers in Oncology 11.
Crossref
Safa Tahmasebi, Elnaz Khosh, Samaneh Rostami & Nima Rezaei. 2022.
Kelly M Wilmas, Quoc-Bao Nguyen, Jigar Patel, Sirunya Silapunt & Michael R Migden. (2021) Treatment of advanced cutaneous squamous cell carcinoma: a Mohs surgery and dermatologic oncology perspective. Future Oncology 17:35, pages 4971-4982.
Crossref
Hailin Zhang, Yonghui Zhang, Jie Dong, Shuguang Zuo, Gang Meng, Junhua Wu & Jiwu Wei. (2021) Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8+ T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma. Cellular Oncology 44:6, pages 1243-1255.
Crossref
Masmudur M. Rahman & Grant McFadden. (2021) Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy. Cancers 13:21, pages 5452.
Crossref
Anastasiya V. Lipatova, Alesya V. Soboleva, Vladimir A. Gorshkov, Julia A. Bubis, Elizaveta M. Solovyeva, George S. Krasnov, Dmitry V. Kochetkov, Pavel O. Vorobyev, Irina Y. Ilina, Sergei A. Moshkovskii, Frank Kjeldsen, Mikhail V. Gorshkov, Peter M. Chumakov & Irina A. Tarasova. (2021) Multi-Omics Analysis of Glioblastoma Cells’ Sensitivity to Oncolytic Viruses. Cancers 13:21, pages 5268.
Crossref
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro & Fabrício Freire de Melo. (2021) Oncolytic virus therapy in cancer: A current review. World Journal of Virology 10:5, pages 229-255.
Crossref
Irina Alekseenko, Alexey Kuzmich, Liya Kondratyeva, Sofia Kondratieva, Victor Pleshkan & Eugene Sverdlov. (2021) Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement. International Journal of Molecular Sciences 22:17, pages 9376.
Crossref
Alexander Malogolovkin, Nizami Gasanov, Alexander Egorov, Marianna Weener, Roman Ivanov & Alexander Karabelsky. (2021) Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes. Viruses 13:7, pages 1271.
Crossref
Tina Briolay, Tacien Petithomme, Morgane Fouet, Nelly Nguyen-Pham, Christophe Blanquart & Nicolas Boisgerault. (2021) Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Molecular Cancer 20:1.
Crossref
Hailin Zhang, Yonghui Zhang, Jie Dong, Binghua Li, Chun Xu, Min Wei, Junhua Wu & Jiwu Wei. (2021) Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance. Molecular Therapy - Oncolytics 20, pages 12-22.
Crossref
Tereza Brachtlova, Jan-Willem van Ginkel, Mark J. Luinenburg, Renée X. de Menezes, Danijela Koppers-Lalic, D. Michiel Pegtel, Wenliang Dong, Tanja D. de Gruijl & Victor W. van Beusechem. (2020) Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format. Molecular Therapy - Oncolytics 19, pages 332-343.
Crossref
Jing Cai, Kaiying Lin, Wei Cai, Yuan Lin, Xincheng Liu, Li Guo, Jifu Zhang, Wencang Xu, Ziqing Lin, Chun Wa Wong, Max Sander, Jun Hu, Guangmei Yan, Wenbo Zhu & Jiankai Liang. (2020) Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1 . Molecular Oncology 14:12, pages 3153-3168.
Crossref
Georgia Schilling & Dirk Arnold. (2020) Grundlagen der ImmuntherapieBasic principles of immunotherapy. Der Radiologe 60:8, pages 682-686.
Crossref
M López González, R van de Ven, H de Haan, J Eck van der Sluijs, W Dong, V W van Beusechem & T D de Gruijl. (2020) Oncolytic adenovirus ORCA-010 increases the type 1 T cell stimulatory capacity of melanoma-conditioned dendritic cells. Clinical and Experimental Immunology 201:2, pages 145-160.
Crossref
Oliver S. Eng & Yuman Fong. 2020. Cancer Regional Therapy. Cancer Regional Therapy 451 460 .
Mee Y. Bartee, Parker C. Dryja & Eric Bartee. (2019) Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Vaibhav Verma, Geeti Sharma & Abhijai Singh. (2019) Immunotherapy in extensive small cell lung cancer. Experimental Hematology & Oncology 8:1.
Crossref
Otto L.D. Cerqueira, Gissele Rolemberg Oliveira Silva, Igor de Luna Vieira, Marlous Vinícius Gomes Lana, Nadine Gimenez, Otavio Augusto Rodrigues, Paulo Roberto Del Valle, Samir Andrade Mendonça & Bryan E. Strauss. 2019. In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders. In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders.
Nashwa Abd El-Aziz, Ghada El Gohary, Sherif Mohamed & Khaled El-Saleh. 2019. Lymphocytes. Lymphocytes.
Tereza Brachtlova & Victor van Beusechem. (2018) Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens. Cells 7:12, pages 228.
Crossref
Aleksei A. Stepanenko & Vladimir P. Chekhonin. (2018) A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy. Gene.
Crossref
Nikolas Tim Martin & John Cameron Bell. (2018) Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones. Molecular Therapy 26:6, pages 1414-1422.
Crossref
Anita G. M. Stam & Tanja D. de Gruijl. 2018. Irreversible Electroporation in Clinical Practice. Irreversible Electroporation in Clinical Practice 249 270 .
Joshua D Freedman, Joachim Hagel, Eleanor M Scott, Ioannis Psallidas, Avinash Gupta, Laura Spiers, Paul Miller, Nikolaos Kanellakis, Rebecca Ashfield, Kerry D Fisher, Margaret R Duffy & Leonard W Seymour. (2017) Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies. EMBO Molecular Medicine 9:8, pages 1067-1087.
Crossref
Jolien De Munck, Alex Binks, Iain A McNeish & Joeri L Aerts. (2017) Oncolytic virus-induced cell death and immunity: a match made in heaven?. Journal of Leukocyte Biology 102:3, pages 631-643.
Crossref
Jing CaiYuan LinHaipeng ZhangJiankai LiangYaqian TanWebster K. Cavenee & Guangmei Yan. (2017) Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics. Proceedings of the National Academy of Sciences 114:26, pages 6812-6817.
Crossref
Carlos Alberto Fajardo, Sonia Guedan, Luis Alfonso Rojas, Rafael Moreno, Marcel Arias-Badia, Jana de Sostoa, Carl H. June & Ramon Alemany. (2017) Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy. Cancer Research 77:8, pages 2052-2063.
Crossref
Lulu Hu, Ke Jiang, Chan Ding & Songshu Meng. (2017) Targeting Autophagy for Oncolytic Immunotherapy. Biomedicines 5:4, pages 5.
Crossref
Amelia Aitken, Dominic Roy & Marie-Claude Bourgeois-Daigneault. (2017) Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. Biomedicines 5:4, pages 3.
Crossref
Sara E. Berkey, Steve H. Thorne & David L. Bartlett. 2017. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy 157 172 .
Zahid Delwar, Kaixin Zhang, Paul S. Rennie & William Jia. (2016) Oncolytic virotherapy for urological cancers. Nature Reviews Urology 13:6, pages 334-352.
Crossref
Lily Francis, Zong Sheng Guo, Zuqiang Liu, Roshni Ravindranathan, Julie A. Urban, Magesh Sathaiah, Deepa Magge, Pawel Kalinski & David L. Bartlett. (2016) Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer. Oncotarget 7:16, pages 22174-22185.
Crossref
Nikolaos F. Pistamaltzian, Sonia A. Perez & Constantin N. Baxevanis. (2016) Reinstating endogenous antitumor immunity: The concept of therapeutic management of cancer. Forum of Clinical Oncology 7:1, pages 4-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.